Oncimmune Holdings plc announced that Dr Adam M Hill will be stepping down as Chief Executive Officer, and as a director of the Company. Adam will support Oncimmune in the short term by providing continuity in some of the Company's ongoing commercial efforts and supporting a transition of his responsibilities and relationships to the new CEO and other colleagues as appropriate. Pending the appointment of a permanent successor, the Board has appointed Ron Kirschner, the Company's General Counsel and Company Secretary, as acting CEO, and a director of the Company.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
25.14 GBX | +4.77% | +7.00% | -0.22% |
29/02 | EARNINGS: Leeds awaiting Hemmers sale, Macfarlane ups full-year payout | AN |
29/02 | Oncimmune Holdings plc Provides Earnings Guidance for the Year 2024 | CI |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-0.22% | 2.23Cr | |
+8.12% | 7.28TCr | |
-10.56% | 513.48Cr | |
+58.79% | 499.2Cr | |
+4.07% | 389.76Cr | |
-16.90% | 248.12Cr | |
+18.30% | 242.35Cr | |
-26.13% | 231.8Cr | |
+19.31% | 216.8Cr | |
-0.50% | 164.41Cr |
- Stock Market
- Equities
- ONC Stock
- News Oncimmune Holdings plc
- Oncimmune Holdings plc Announces Executive Changes